|

Malaria interventions coverage
| Indicator |
2002 |
2005 |
| % pregnant women sleeping under insecticide-treated mosquito nets |
3 |
50 |
| % children with fever receiving any anti-malarial medicines |
4 |
- |
| % children with fever receiving any anti-malarial medicines promptly (within 24 hours) |
2 |
- |
| % children with fever receiving any anti-malarial medicines |
4 |
- |
| % children sleeping under insecticide-treated mosquito nets |
4 |
59 |
| % children sleeping under any type of mosquito net |
12 |
- |
| Household availability of at least one mosquito net of any type (%) |
34 |
- |
Source of the data: DHS 2002; NMCP
- I. Epidemiological background
-
| Parasite (Plasmodium) types |
The main parasites are Plasmodium falciparum and Plasmodium Vivax. The parasite distribution (2005) was P.falciparum (83%) and P.vivax (17%). |
| Main vector (mosquito) types |
The vector is almost exclusively Anopheles arabiensis. |
| Total population |
3,990,36 (2006) |
| Population at risk |
2,673,546 (2006) |
| 67% of the Population lives in areas at risk of malaria:
41 out of the 58 sub-zonas (Sub-regions). |
| Transmission |
Malaria transmission in Eritrea is highly seasonal and unstable: There are two main malaria transmission seasons: September – November (for central, southern, western lowlands) and January – March (for the coastal plains). In brief, malaria is seasonal, focal, and unstable with a risk for malaria epidemics. |
| Women aged between 15-45 years of age at risk of malaria |
528,900 (2006) |
| Children under five at risk of malaria |
432,000 (2006) |
| Number of reported clinical malaria / fever cases |
14,148 (2006) |
| Child under 5 malaria mortality |
9 (2006) |
| Infant mortality (per 1000) |
50 (2005) |
Source of the data: WHO statistics 2007
- II. Current Policy and Strategy
-
Primary interventions: Policy
| Case management |
- 1st line treatment for uncomplicated falciparum malaria is Artesunate + Amodiaquine (AS+AQ).
- The 2nd treatment for treatment failures is oral Quinine.
- The treatment for severe malaria is parenteral Quinine.
- Treatment of malaria during the pregnancy is Quinine in all trimesters but AS+AQ might be considered when Quinine is not available and when the benefit outweighs the risk.
- The treatment of malaria in areas where confirmation of malaria either by microscopy or RDTs is NOT possible is CQ+SP.
|
| Prevention |
- The use of ITNs, Larviciding, Indoor residual spraying in selected villages
- Malaria prevention during the pregnancy:
ITNs are provided freely by the health facilities to all the pregnant women who attend ANC during their 1st clinic visit and also during and after delivery.
|
| Primary interventions: Strategy |
- Case Management
Early detection and prompt treatment
- Integrated Vector Management:
(Environmental Management, Use of ITNs, Larviciding, Indoor residual spraying in selected villages)
- Epidemic Prevention
(forecasting, monitoring of sentinel sites, preparedness)
- Capacity Building
(Training of Health workers, Community Health Agents, Public Health Technicians etc.)
- Health Promotion
- Operational Research
- Monitoring and Evaluation
|
- III. Primary interventions
-
[+] ITNs
[+] Indoor residual spraying (IRS)
[+] Malaria IPD
[+] View data
| Indicators |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
| Number of ITNs distributed |
245,000 |
387,000 |
472,000 |
660,000 |
875,000 |
982,000 |
1,063,000 |
| Malaria OPD Cases |
109,578 |
125,746 |
74,861 |
65,517 |
27,783 |
24,192 |
10,148 |
| Total <5 IPD |
1,300 |
1,900 |
1,350 |
1,550 |
850 |
975 |
775 |
| Total malaria IPD |
7,800 |
8,900 |
6,800 |
8,900 |
4,200 |
6,900 |
4,000 |
| U5 malaria deaths |
30 |
45 |
32 |
28 |
6 |
2 |
9 |
| Total malaria deaths |
85 |
129 |
85 |
70 |
16 |
32 |
25 |
- IV. Challenges and Priority support needs (2008 - 2010)
-
Challenges
The significant reduction of malaria morbidity creates other challenging issues/factors:
- low immunity of population, tendency to develop severe malaria and prone to malaria epidemics;
- challenge of sustaining the achievements and successes obtained;
- creates complacence/relaxation among population, MOH, Partners among others;
- generally limited infrastructure (transport, laboratory, communications);
- generally limited trained human resources in the General Health Delivery System;
- generally limited data base for linking epidemiological, entomological, ecological, and climate-related data to predict epidemics;
- general concern of sustaining community based interventions (bednet issues, source reduction, case management) ownership and support for community health agents (CHAs) incentives;
- cross-border malaria concern.
|
Support needs (TA and Finance)
- Updating of AMDs Policy, dissemination and training of HWs and CHAs;
- Procurement of adequate AMDs (ACTs);
- Procurement of adequate RDTs;
- Procurement of LLINs, insecticides etc;
- Improve the early treatment seeking behavior and use of ITNs of the population and particularly of the vulnerable groups (<5, pregnant women, the military & other non immune population) by conducting aggressive HP/BCC activities;
- Goluj Project and Construction of ware house in Gash Barka (which has already eaten too much time).
|
- V. Key RBM Partners in Ertrea
-
- National Government Contribution – big and continuous
- GFATM – The second biggest financial support since the end of 2003
- Local associations/NGOs, ministries, communities – big & continuous
- WHO - Technical & Financial since 1995
- UNICEF – Technical & Financial since 1995
- IDA/World Bank – Big Financial & technical support since 1998
- Italian Cooperation/PHARPE – Financial support since 1997
- JICA: Japan International Cooperation Agency – Material support (c. 30,000 LLINs/yr.) since 2003/4
Source: NMCP Eritrea
For questions, contact Ms Nadia Lasri, RBM Partnership facilitation Dr J. Banda, RBM Partnership facilitation Coordinator,
Dr Tewolde Ghebremeskel , National Malaria Control Programme Manager
|